Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Pusey

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Nature Reviews. Nephrology|March 17, 2017
Glomerular disease: Crescentic glomerulonephritis: beyond the immune systemPhilip Webster, Charles Pusey
Clinical Medicine (London, England)|January 20, 2005
Clinical academic medicine: the way forwardCharles Pusey, Rajesh Thakker
Presse Medicale (Paris, France : 1983)|November 10, 2019
Plasma exchange in anti-glomerular basement membrane diseaseMaria Prendecki, Charles Pusey
Nature Reviews. Nephrology|October 2, 2013
Vasculitis syndromes: RAVE about rituximab in ANCA vasculitis?Ruth Tarzi, Charles Pusey
Nature Reviews. Nephrology|January 21, 2015
Clinical trials. Rituximab for maintenance of remission in AAVAnisha Tanna, Charles Pusey
Hospital Medicine (London, England : 1998)|May 14, 2005
Is there a future for academic medicine in the UK?Charles Pusey, Rajesh Thakker
Rheumatology (Oxford, England)|March 18, 2019
Comment on: A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis: replyAlan Salama, Ruth Pepper, Stephen Mcadoo, et al.
Rheumatology (Oxford, England)|March 12, 2025
Highlights from the breakout session: optimising new treatmentsLucy Francis, Amrita Dhutia, Charles Pusey, et al.
Rheumatology (Oxford, England)|January 17, 2019
Comment on: A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis: replyRuth Pepper, David Jayne, Mark Little, et al.
International Journal of Molecular Sciences|January 28, 2021
Immunomodulatory Properties of Mesenchymal Stromal Cells Can Vary in Genetically Modified RatsNatalie Vallant, Bynvant Sandhu, Karim Hamaoui, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Nature Reviews. Nephrology|March 17, 2017
Glomerular disease: Crescentic glomerulonephritis: beyond the immune systemPhilip Webster, Charles Pusey
Clinical Medicine (London, England)|January 20, 2005
Clinical academic medicine: the way forwardCharles Pusey, Rajesh Thakker
Presse Medicale (Paris, France : 1983)|November 10, 2019
Plasma exchange in anti-glomerular basement membrane diseaseMaria Prendecki, Charles Pusey
Nature Reviews. Nephrology|October 2, 2013
Vasculitis syndromes: RAVE about rituximab in ANCA vasculitis?Ruth Tarzi, Charles Pusey
Nature Reviews. Nephrology|January 21, 2015
Clinical trials. Rituximab for maintenance of remission in AAVAnisha Tanna, Charles Pusey
Hospital Medicine (London, England : 1998)|May 14, 2005
Is there a future for academic medicine in the UK?Charles Pusey, Rajesh Thakker
Rheumatology (Oxford, England)|March 18, 2019
Comment on: A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis: replyAlan Salama, Ruth Pepper, Stephen Mcadoo, et al.
Rheumatology (Oxford, England)|March 12, 2025
Highlights from the breakout session: optimising new treatmentsLucy Francis, Amrita Dhutia, Charles Pusey, et al.
Rheumatology (Oxford, England)|January 17, 2019
Comment on: A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis: replyRuth Pepper, David Jayne, Mark Little, et al.
International Journal of Molecular Sciences|January 28, 2021
Immunomodulatory Properties of Mesenchymal Stromal Cells Can Vary in Genetically Modified RatsNatalie Vallant, Bynvant Sandhu, Karim Hamaoui, et al.
Pageof 5